A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.
Sied KebirTeresa SchmidtMatthias WeberLazaros LazaridisNorbert GalldiksKarl-Josef LangenChristoph KleinschnitzElke HattingenUlrich HerrlingerPhilipp LohmannMartin GlasPublished in: Cancers (2020)
Pseudoprogression (PSP) detection in glioblastoma remains challenging and has important clinical implications. We investigated the potential of machine learning (ML) in improving the performance of PET using O-(2-[18F]-fluoroethyl)-L-tyrosine (FET) for differentiation of tumor progression from PSP in IDH-wildtype glioblastoma. We retrospectively evaluated the PET data of patients with newly diagnosed IDH-wildtype glioblastoma following chemoradiation. Contrast-enhanced MRI suspected PSP/TP and all patients underwent subsequently an additional dynamic FET-PET scan. The modified Response Assessment in Neuro-Oncology (RANO) criteria served to diagnose PSP. We trained a Linear Discriminant Analysis (LDA)-based classifier using FET-PET derived features on a hold-out validation set. The results of the ML model were compared with a conventional FET-PET analysis using the receiver-operating-characteristic (ROC) curve. Of the 44 patients included in this preliminary study, 14 patients were diagnosed with PSP. The mean (TBRmean) and maximum tumor-to-brain ratios (TBRmax) were significantly higher in the TP group as compared to the PSP group (p = 0.014 and p = 0.033, respectively). The area under the ROC curve (AUC) for TBRmax and TBRmean was 0.68 and 0.74, respectively. Using the LDA-based algorithm, the AUC (0.93) was significantly higher than the AUC for TBRmax. This preliminary study shows that in IDH-wildtype glioblastoma, ML-based PSP detection leads to better diagnostic performance.
Keyphrases
- newly diagnosed
- computed tomography
- machine learning
- end stage renal disease
- contrast enhanced
- positron emission tomography
- chronic kidney disease
- pet ct
- magnetic resonance imaging
- peritoneal dialysis
- low grade
- squamous cell carcinoma
- magnetic resonance
- palliative care
- multiple sclerosis
- body composition
- high resolution
- subarachnoid hemorrhage
- wild type
- real time pcr
- cerebral ischemia